Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ichimura K et al. – The data indicate that IDH1 mutation combined with either TP53 mutation or total 1p/19q loss is a frequent and early change in the majority of oligodendroglial tumors, diffuse astrocytomas, anaplastic astrocytomas, and secondary glioblastomas but not in primary glioblastomas.

Related Articles

Glioblastoma with signet-ring morphology: a case report and review of the literature
Human Pathology, 12/08/09    Relevance Score: 67%

Characterization of R132H Mutation-specific IDH1 Antibody Binding in Brain Tumors
Brain Pathology, 11/11/09    Relevance Score: 64%

Provincial primary care and cancer engagement strategy
Canadian Family Physician, 11/16/09    Relevance Score: 45%

Short-term outcomes in patients attending a primary care-based addiction shared care program
Canadian Family Physician, 11/16/09    Relevance Score: 45%

The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancer
Acta Oncologica, 11/02/09    Relevance Score: 45%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address